Nationales Centrum für Tumorerkrankungen Heidelberg

Heidelberg 69120

0 studies enrolling now · 4 studies all time

What they study most

Adenoid Cystic Carcinoma, Breast Cancer, Colorectal Cancer, Glomus Tumor, Malignant, HNSCC, Hepatocellular Carcinoma, Locally Advanced or Unresectable Metastatic Breast Cancer, Metastatic Breast Cancer, Non-hodgkin Lymphoma, Osteosarcoma, Stage IV Breast Cancer, T-ALL

Studies at this site

• Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC — Completed
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
• Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies — Stopped early